MIMRYLO™ is the First and Only Hepcidin Mimetic Peptide Therapy Approved for the Treatment of Erythrocytosis in Adults ...
By Kamal Choudhury and Mariam Sunny Aug 28 (Reuters) - The U.S. Food and Drug Administration has approved a first-of-its-kind ...
Protagonist Therapeutics (NASDAQ:PTGX) said the U.S. Food and Drug Administration has approved rusfertide, to be marketed as ...
Metro 2039 will feature a new speaking protagonist, The Stranger, which allowed 4A Games to tell a darker, more personal ...
U.S. Food and Drug Administration approval of MIMRYLO, or rusfertide, for erythrocytosis in adults with polycythemia vera ...
Protagonist Therapeutics' (PTGX) future growth will hinge more on its wholly owned programs than on its newly approved partner therapy, with the company's first clinical readouts ...
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...
One Piece's upcoming movie release will see Luffy taking the backseat, and a new protagonist officially taking over.
This article contains Tenet spoilers. The Protagonist might be one of the most unimaginatively named main characters of all time, but it’s worth pointing out that he is referred to as “the ...